Currently, this novel agent is in limited supply outside of research programs . Securing it requires qualification in a approved research study , which is typically conducted at select medical centers . https://glp-3-retatrutide-for-sa634913.pointblog.net/accessing-the-medication-access-how-to-get-a-glp-3-agonist-treatment-95216365